At least 10% of children with intracranial central nervous system (CNS) tumors suffer from seizures. These seizures may occur preoperatively, postoperatively, or both. Postoperative seizures are classified as early (occurring within one week of surgery) or late. 1 In all cases, uncontrolled seizures in young children can have severe effects on cognitive and psychosocial development. Despite the importance of this problem, seizure rates following brain tumor resections in children have not been fully evaluated.
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can have several side effects, including diplopia, dizziness, hyponatremia, nausea, sedation, gingival hyperplasia, tremor, weight gain, nephrolithiasis, and others. 3, 4 These drugs may provide the patient with a seizure-free recovery but also carry the potential to worsen his/her quality of life.
To help guide the management of these patients, this study examines the prevalence of postoperative seizures in children who have had resection of supratentorial tumors, and identifies risk factors for postoperative seizure development in these patients.
Methods
Approval from the institutional review board was obtained prior to initiation of this study. The hospital's electronic medical records were retrospectively screened using code from the International Classification of Diseases, Ninth Revision, for pediatric patients between the ages of 0 and 21 years with supratentorial tumor resection occurring at the institution between 2005 and 2015. Patients undergoing biopsy-only procedures were excluded. AEDs were not used prophylactically in seizure-free patients undergoing resection for supratentorial tumor.
Predictor and Outcome Variables
All inpatient and outpatient electronic medical records were reviewed. Data recorded included gender, age, tumor location, extent of resection, pathology, presence and timing of seizures, chemotherapy if given, radiation therapy if given, presence of hydrocephalus and sodium levels. Age less than 2 years old was distinguished as a categorical variable as patients in this group are considered a unique clinical entity due to immature neurocognitive status, late clinical presentation, special histological findings, and poor surgical morbidity. 5 Seizures were stratified by onset (early and late) and type (focal or generalized).
Extent of Resection
Tumor characteristics and extent of resection were assessed by a neuroradiologist at the time of surgery based on comparison of pre-and postoperative MRI. Gross total resection (GTR) was defined as complete resection of the preoperative enhancing area with no residual enhancement on MRI. The extent of resection was recorded from postoperative and follow-up MRI reports.
Tumor Location
Tumors were classified into 12 intracranial locations: sellar or suprasellar, lateral ventricle, third ventricle, corpus callosum, thalamus, pineal, basal ganglia, and choroid plexus, in addition to the 4 cerebral lobes-frontal, temporal, parietal, and occipital. Each tumor location was considered an independent binary outcome, since many patients had tumors in more than one supratentorial location.
Histopathology
Tumors were grouped into 9 histopathological groups based on the 2016 World Health Organization (WHO) classification of CNS tumors. These were astrocytic and oligodendroglial tumors (diffuse astrocytic and oligodendroglial tumors and other astrocytic tumors), ependymal tumors, choroid plexus tumors, neuronal and mixed neuronal-glial tumors, tumors of the pineal gland, embryonal tumors, germ cell tumors, tumors of the sellar region and other gliomas. Other gliomas (N = 1) included one angiocentric glioma as per WHO classification.
Classification of Postoperative Sodium Levels
Sodium levels in serum before and after surgery were classified according to the range established by our institution's department of pathology. Any value less than 135 mEq/L was considered hyponatremia and any value above 145 mEq/L was considered hypernatremia. Sodium values between 135 mEq/L and 145 mEq/L were considered normal. All recorded sodium measurements from the admission for surgical resection were included.
Statistical Analysis
Bivariate analysis of categorical outcome variables was performed using chi-square contingency tables or Fisher's exact test, while Student's t-test, ANOVA, and the MannWhitney test were used for continuous outcome variables.
Importance of the study
While AEDs may provide patients with a seizure-free recovery, these drugs carry the potential to worsen the patient's quality of life. To understand the context in which preemptive prescription of AEDs is warranted, this study aims to provide an estimate of the prevalence of seizures post resection of supratentorial tumors in pediatric patients, and identify the demographic, pathological, and surgical risk factors for postoperative seizure development in this patient population.
This study serves as a preliminary guide for postoperative management of seizures in the studied population. Institutions that promote the prophylactic prescription of AEDs to pediatric patients after intracranial tumor resection should evaluate the necessity of this practice with respect to the risk factors identified herein. Further prospective studies capable of a robust analysis of the demographic, surgical, and pathological risk factors for seizures in this setting are warranted.
P-values ≤0.05 were considered significant. A bivariate logistic regression was conducted for significant variables (P-value ≤0.05) and borderline significant variables, and crude odds ratios (ORs) with their 95% confidence intervals (CIs) were generated. A stepwise logistic regression was then used to generate a final model starting with all significant and borderline significant variables. Borderline significance was set at a cutoff P-value of 0.2, in order to be inclusive and avoid any missed confounding variables. Adjusted ORs and their CIs were reported. Data were analyzed using the Statistical Package for the Social Sciences version 22.0.
Results
Demographics and Treatment Status
Two hundred pediatric patients met the criteria for inclusion in this study. Demographics and treatment status are reported in Table 1 . Female:male ratio was approximately 3:4. Median age (± SD) at surgery was 9.03 ± 5.72 years (range 1.2 mo-23.5 y), with a mean follow-up of 4 ± 2 years (range from initial visit). Twenty-five patients (13%) were under 2 years of age. Prior to attempted GTR, 30 (15%) patients received chemotherapy and 12 (6%) received radiation therapy. Gross total resection was confirmed in 82 (41%) cases.
Seizure Prevalence
Overall 99 patients (49.5%) experienced seizures-either before surgery, after surgery, or both. Of these ninety-nine, 32 (16% of total cohort) had strictly preoperative seizures, 33 (16.5%) had strictly postoperative seizures, while 34 patients experienced seizures both prior to and following resection. The median time to first postoperative seizure was 3.4 months (range 1 d-9 y).
Postoperative seizures were classified by seizure type and onset-44 patients (22%) experienced focal seizures, 25 (13%) experienced generalized, and 2 (1%) experienced both types. Information from the records of 1 patient was insufficient to determine seizure type. Among the 67 patients with postoperative seizures, 49 (73%) had lateonset seizures and 18 (27%) had early-onset seizures.
Age
The median age of patients (± SD) with postoperative seizures (8.49 ± 6.24 y) did not differ significantly from that of seizure-free patients (9.67 ± 5.42 y; P = 0.167, MannWhitney U test). Stratifying patients according to seizure onset, patients with early seizures (n = 18; median age = 5.75 ± 6.67 y) were on average almost 4 years younger at surgery than those without (n = 182; median = 9.62 ± 5.52 y; P = 0.006, univariate ANOVA), while median age did not differ regarding patients with late-onset seizures (median = 8.48 ± 6.02 y; P = 0.213, univariate ANOVA; data not shown). Stratifying according to seizure type, patients with focal postoperative seizures (n = 44; median = 7.72 ± 5.47 y) were on average 2 years younger than those not developing focal postoperative seizures (n = 155; median = 9.67 ± 5.73 y; P = 0.045, univariate ANOVA; data not shown).
Twenty-five of the total 200 (13%) tumor patients were under 2 years of age (Table 1) . Patients in this subgroup experienced postoperative seizures at double the rate of those older than 2 (60% vs 30%, respectively; P = 0.003; Pearson chi-square test). The proportion of patients under 2 with early-onset seizures was 7-fold that of those older than 2 (36% vs 5%, respectively; P < 0.001; Fisher's exact test).
Preoperative Seizures
Thirty-four of 66 patients (52%) presenting with preoperative seizures developed postoperative seizures (P < 0.001; Pearson chi-square test). Twenty-four patients (36%) with preoperative seizures had late postoperative seizures 
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(P = 0.006; Pearson chi-square test), and 26 patients (39%) had partial seizures (P < 0.001; Pearson chi-square test), while no association was found with generalized seizures (P = 0.497; Pearson chi-square test; Table 2 ). Stratifying patients according to seizure type, 18 (56%) with focal preoperative seizures had postoperative seizures (P = 0.004; Pearson chi-square test), which represents nearly double the rate of those without focal preoperative seizures (29.7%). Seventeen patients (52%) with generalized preoperative seizures had postoperative seizures (P = 0.020; Pearson chi-square test), compared with those without generalized postoperative seizures (50 patients, 30.5%). Interestingly, most patients with focal preoperative seizures (n = 17, 53%) developed focal postoperative seizures (P < 0.001; Pearson chi-square test), and patients with generalized preoperative seizures (n = 8, 24%) had higher rates of generalized postoperative seizures compared with those with no prior generalized seizures (n = 17, 10%; P = 0.043; Fisher's exact test; data not shown). Table 3 displays the breakdown of supratentorial tumors by 12 intracranial locations. Of the cerebral lobes, the frontal (18%) and temporal (17%) were most commonly involved, with the occipital least involved (6%). Fifteen (8%) patients had a lesion extending into more than one lobe, while 20% of our total cohort had tumors infiltrating 2 or more of the 8 remaining supratentorial locations.
Tumor Location
Patients with tumors located in the temporal lobe (n = 34) experienced postoperative seizures (n = 22; 65%) at a rate nearly double that of patients with nontemporal tumors (n = 45; 27%; P < 0.001; Pearson chi-square test).
Six (3%) patients of the overall cohort had lesions located in the thalamus, of which 5 patients (83%) had postoperative seizures (P = 0.017; Fisher's exact test; Table 2 ).
As would be expected, patients with sellar and suprasellar tumors had low seizure rates. Patients with sellar/ suprasellar tumors accounted for 35% (n = 70) of our overall cohort (Table 3 ). Of these, 12 patients (17%) had postoperative seizures, a rate 2½ times less than that of patients with nonsellar tumors (n = 55, 42%; P < 0.001; Pearson chi-square test). Patients with lesions in the frontal lobe (n = 36, 18% of total) experienced late-onset seizures at a higher rate than those without (n = 14, 39% vs n = 35, 21%, respectively; P = 0.027; Pearson chi-square test). No correlation was found between frontal tumors and seizure type (data not shown).
The overall post-resection seizure rate did not vary according to any of the remaining 8 locations (Table 3) . Seizure onset and type did feature some additional associations with tumor location. Patients with either multiple-location tumors (P = 1.000; Pearson chi-square test) or tumors extending into more than one cerebral lobe (P = 0.989; Pearson chi-square test) experienced seizures at rates similar to those of their counterparts, regardless of onset and type. Table 4 displays the statistical breakdown of our cohort by 4 WHO grades. More than half (62%) of all patients had grade I tumors, 14% had grade IV tumors. The proportion of postoperative seizure increased in a stepwise fashion according to WHO grade (Table 4) , with grade IV patients experiencing more than double the rate of grade I patients (54% and 25%, respectively; P = 0.008; Pearson chi-square test; Table 4 ). Table 5 displays the statistical breakdown of our cohort by tumor pathology. Astrocytic and oligodendroglial tumors were most commonly represented in our cohort, present in 76 (38%) patients, followed by sellar tumors (n = 41, 20.5%). Pineal (n = 3, 2.5%) and other gliomas (n = 1, 0.5%) were the least commonly represented.
Tumor Grade
Tumor Pathology
The patterns of overall postoperative seizure, seizure onset, and seizure type varied with respect to tumor pathology (Table 5) . Patients with embyronal tumors and pineal tumors experienced postoperative seizures at the highest rate (n = 10, 62.5% and n = 2, 66.7%, respectively; P = 0.005;
Fisher's exact test). In concert with our findings on fewer seizures in patients with tumors located in the sellar or suprasellar region, those with craniopharyngiomas experienced both the lowest overall and late-onset seizure rate (n = 5, 12.2% and n = 4, 9.8%, respectively; P = 0.005 and P = 0.001; Fisher's exact test; Table 5 ).
Hydrocephalus
Seventy-five of 200 patients in our total cohort were diagnosed with hydrocephalus (Table 2) . Hydrocephalus onset was preoperative in 65/75 patients and postoperative in 57. Preoperative hydrocephalus (n = 27, 42%) was not significantly associated with postoperative seizures compared with patients without preoperative hydrocephalus (n = 40, 30%; P = 0.095; Pearson chi-square test). Stratifying patients according to seizure onset, the rate of early seizure onset was 14% greater in patients with preoperative hydrocephalus than in those without (P = 0.001; Pearson chi-square test). Stratifying patients according to seizure type, 15 of 64 patients with preoperative hydrocephalus (23%; one case with insufficient data) had generalized postoperative seizures in contrast to those not developing preoperative hydrocephalus (n = 10, 7%; P = 0.001; Pearson chi-square test; Table 2 ). Concerning postoperative hydrocephalus, 28 patients (49%) had postoperative seizures compared with those without hydrocephalus (n = 39, 27%; P = 0.003; Pearson chi-square test). Seizures tended to occur late after resection in patients with postoperative hydrocephalus (n = 22, 39%; P = 0.046; Pearson chi-square test; data not shown). 
Sodium Levels
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unit lower preoperative sodium levels than those without (140.56 ± 2.84 mEq/L; P = 0.088). Patients with partial/focal postoperative seizures (139.25 ± 3.78 mEq/L) did feature a mean preoperative sodium reading (still within the normal range) 2 units lower than patients without (140.58 ± 3.16 mEq/L; P = 0.02). Similarly, patients with postoperative seizures had around 3 units lower postoperative sodium levels (140.04 ± 9.16 mEq/L) compared with patients without postoperative seizures (142.98 ± 10.68 mEq/L; P = 0.056). Again, patients with partial/focal postoperative seizures (138.32 ± 7.46 mEq/L) featured a mean postoperative sodium reading 5 units lower those of their counterparts (143.03 ± 10.75 mEq/L; P = 0.007). Long-term sodium levels did not vary according to seizure onset or type (P > 0.05). Student's t-test was used for all continuous sodium levels.
Sodium levels were also assessed categorically-below, above, or within the normal range of 135-145 mEq/L. Data were available for 199 patients. Twelve patients were each noted to have sodium irregularities preoperatively: 6 (3%) below and 6 above the normal range. Sixty-one patients had sodium irregularities after surgery: 24 (12%) below and 36 above. Five patients (83%) with preoperative hyponatremia experienced postoperative seizures (P = 0.017; Fisher's exact test), with all 5 having late-onset (P = 0.004; Fisher's exact test). Neither seizure type nor onset was associated with hypernatremia prior to surgery (P = 0.675; Pearson chi-square test).
Regarding postoperative sodium irregularities, our categorical analyses tended to concur with the quantitative: 11 patients (44%) with postoperative hyponatremia developed postoperative seizures compared with 56 patients (32%) with no hyponatremia (P = 0.234; Pearson chi-square test). Results were not statistically significant even when stratified according to type (P = 0.203; Pearson chi-square test, P = 1.000; Fisher's exact test for focal and generalized seizures, respectively) or onset (P = 0.664, P = 0.191 for late and early seizures, respectively; Pearson chi-square test; data not shown). Longterm sodium measurements assessed categorically did not vary by seizure onset or type (P > 0.200; Pearson chisquare test). (8) 10 (63) 4 (25) 10 (63) 5 (31) 5 (31) Germ cell 16 (8) 3 (19) 2 (13) 3 (19) 1 (6) 2 (13) Sellar 41 (20.5) 5 (12) 3 (7) 4 (10) 3 (7) 3 (7) Other gliomas 1 (0.5) 
Preoperative Chemotherapy
0 (0) 0 (0) 0 (0) 0 (0) 0 (0) P-
Additional Factors
Preoperative radiation therapy, extent of resection, and sex did not have any associations with overall postoperative seizures, seizure onset, or seizure type (all P > 0.20; Pearson chi-square test).
Multifactorial Analysis
In order to identify robust risk factors for the development of postoperative seizure, a series of binary logistic regressions were done. Multiple permutations of each model and models of highest overall value are presented here. Factors included were: preoperative seizures, age less than 2 years, tumor pathology (all pathologies included), location (all locations included), preoperative hydrocephalus, and preoperative hyponatremia. Table 6 displays the results of this model assessing overall seizure status post-resection. Including 199 patients, the model was statistically significant (P < 0.0001) with an overall correct classification rate of 80%, fourteen points greater than that of the null. Of the 9 factors included, 5 remained independently associated with the binary outcome: temporal location (OR 4.7, 95% CI: 1.7-13.3, P < 0.01), age less than 2 years (OR 3.9, 95% CI: 1.0-15.4; P = 0.05), preoperative hydrocephalus (OR 3.8, 95% CI: 1.5-9.4; P < 0.01), preoperative seizure (OR 2.8, 95% CI: 1.2-6.5; P = 0.01), and parietal location (OR 0.25, 95% CI: 0.06-0.99; P = 0.05). Thalamic location (OR 9.5, 95% CI: 0.85-111.1; P = 0.07) and preoperative hyponatremia (OR 6.3, 95% CI: 0.59-66.7; P = 0.13) were not significantly associated with postoperative seizures. Based on the statistical test for goodness of fit, the multivariable analysis model fits the data adequately (Hosmer and Lemeshow goodness of fit test = 4.622 (df = 8), P-value = 0.797).
Four of the identified risk factors remained significant in the early postoperative seizures model: temporal location (OR 52.6, 95% CI: 1.9-1000.0, P < 0.05), preoperative hydrocephalus (OR 14.7, 95% CI: 2.1-111.1; P = 0.01), age less than 2 years (OR 8.4, 95% CI: 1.0-71.4; P = 0.05), and preoperative seizure (OR 6.1, 95% CI: 1.6-24.4; P = 0.01). Concerning late postoperative seizures, only 2 risk factors were significant: preoperative hyponatremia (OR 25.0, 95% CI: 2.0-333.3; P = 0.01) and temporal location (OR 2.7, 95% CI: 1.0-7.0, P = 0.05; data not shown).
Discussion
This is one of the few studies that assess seizure development following supratentorial tumor resection in the pediatric population. The aim of this study was 2-fold: to provide an estimate of the prevalence of post-resection seizure development, and secondly, to identify demographic, pathological, and surgical risk factors that may predispose patients to develop such seizures. Together this information could be utilized to help manage these patients effectively.
The findings of this study on seizure prevalence confirmed prior reports. The 16% seizure rate prior to surgery is consistent with Hardesty et al's 12% at initial diagnosis, 6 and the 16.5% strictly postoperative rate lies close to the 5%-15% postoperative seizure rates previously reported. [6] [7] [8] [9] [10] [11] [12] A recent study by Oushy et al on adult patients showed that AEDs should be considered in patients with supratentorial tumors, intraoperative cortical stimulation, and subtotal resections. 13 Our study further explores supratentorial tumors in a population of pediatric patients.
The initial analysis identified several variables with statistically significant relationships with the primary outcome of interest, postoperative seizure development. Temporal lobe location, parietal lobe location, age less than 2 years, preoperative hydrocephalus, and preoperative seizure status were identified as statistically significant risk factors for the outcome of interest using binary logistic regression.
As a continuous variable, age did not reach significance in bivariate testing of overall postoperative seizure development. With respect to seizure onset and type, patients experiencing early postoperative and partial/focal seizures were 4 and 2 years younger than their counterparts, 
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respectively. Age less than 2 defined categorically did however display a significant (P = 0.003) association with overall postoperative seizure status. Hardesty et al reported that age less than 2 years increased the risk for developing postoperative seizures by 21 times compared with patients with age >2 years. 6 These results pointed toward a more modest, but still important 4-fold risk ratio for this group. Brain tumors in patients younger than 2 years are considered a "unique realm of neuro-oncology"; rapid developmental changes concerning tissue growth concomitant with psychological maturation result in broad variations in tumor distribution and neurocognitive status in this population. 5 Altogether, the increased susceptibility to seizure in patients under 2 years of age may be due in part to an immature inhibitory network contributing to an underregulated excitatory network.
Temporal location of tumor mass increased the likelihood of postoperative seizure development 5-fold. According to Bonilha et al, patients with abnormalities within or in proximity to a temporal lobe subnetwork composed of the ipsilateral hippocampus, amygdala, lateral temporal gyri, and insula have an increased risk of postsurgical seizure development. 14 Mahaley et al further suggest that the limbic and temporal areas feature some of the lowest thresholds for seizure induction in humans. 15 Interestingly, thalamic involvement (P = 0.07) featured a massive upper limit in the confidence interval (111.1) and the largest odds ratio (9.5) of any factor for postoperative seizures. This might be due to the many-fold connections from the thalamus to the hippocampus via the mammillothalamic tract. 16 Alternatively, the surgical approach for these intrinsic tumors may have played a significant role in the development of seizures. Considering late-onset seizures only (which in our series were predominantly of partial/focal type), thalamic involvement achieved significance as the preeminent risk factor, with an odds ratio of 12. While this small subcohort of 6 patients is consistent with the low prevalence of thalamic tumors in children, 17, 18 the low n does not preclude the robustness of the findings, particularly in the context of a multivariable regression. In summation, resecting a mass extending into the temporal lobe and or thalamus may disrupt this structural network enough to elevate the risk for seizure development after surgery.
Two factors-sellar/suprasellar and parietal location of intracranial mass-were noted to have inverse relationships with seizure outcome, in that a greater proportion of patients with these radiographic characteristics seemed less likely to experience seizures after resection. The decrease in postoperative seizures in sellar/suprasellar tumors could be explained by the fact that these tumors are mostly managed via a transsphenoidal approach, which has less brain manipulation compared with other techniques, decreasing the risk of seizure occurrence. 19, 20 However, sellar/suprasellar location did not retain significance in binary logistic regression, along with the variable tumor pathology. Parietal tumor resections were shown to decrease postoperative seizures 4-fold (P = 0.049). This finding is consistent with Hardesty et al's study wherein none of the patients with resections of parietal tumors (n = 7) developed seizures postoperatively. 6 Preoperative hydrocephalus increased risk for postoperative seizure development 4-fold. Recent studies into the physiology of hydrocephalus can provide insight into this new finding. Aquaporin 4 (AQP-4), a transmembrane water channel, is involved in the clearance of fluid in the brain. In vivo EEG characterization of seizures induced via electrical stimulation of the hippocampus showed a significantly higher threshold for seizure onset in AQP-4 null mice relative to wild-type mice, causing a decrease in seizure development. 21 Histopathological examination of WHO grades I-IV gliomas from 65 patients between 14 and 71 years of age (mean 50 y) found abnormally high expression of AQP-4, with the highest concentrations sourced to the peritumor area. 22 Furthermore, several studies report a linkage between AQP-4 peritumor status and hydrocephalus in humans and animals. [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] Taken together these studies and our findings point to the following model: hyperexpression of AQP-4 around the tumor in conjunction with mass effect causing obstruction of normal CSF flow contribute to a hydrocephalic state. 34 A resection attempt further destabilizes regulation of fluid gradients, altogether leading to patients' increased susceptibility to seizure onset.
Hardesty et al's 2011 study of 223 pediatric brain tumor patients identified patients with hyponatremia with at least one of 2 criteria: a urine sodium measurement under 130 mEq/L or a urine sodium level of 130-134 mEq/L acquired after a precipitous drop of more than 10 mEq/L over the prior 24 hours. The authors concluded that postoperative hyponatremia increased the risk of seizure development by 15-fold. 6 Williams et al also reported that hyponatremia was found in 12% of patients and leads to postoperative seizures in 21% of patients, highlighting its importance as one of the determinants of postoperative seizures. 35 This study could not identify postoperative hyponatremia as a risk factor for postoperative seizures in a population of patients with supratentorial tumors only. This discrepancy could be attributed to the inclusion of patients with infratentorial tumors in Hardesty's and Williams' studies. Results could not be compared in this regard, since both studies did not include any stratification of postoperative hyponatremia according to tumor location.
Very few reports discuss seizure type and onset after neurosurgical procedures. Seizures occurring early after resection are more likely due to generalized brain dysfunctions such as cerebral edema, leading to generalized seizures. Those occurring late after tumor resection are more likely due to localized brain dysfunction causing focal/partial seizures. Patients recovering from a brain tumor resection are more likely to experience late-onset seizures that are partial/focal in character and more difficult to control than early-onset seizures. 36 While failing to reach significance (P = 0.21), our results generally conform to these patterns: 36 patients (81%) with partial/focal seizures experienced a late-onset (20% more than those with generalized seizures, n = 15), while 10 patients (39%) with generalized seizures had an early-onset (20% more than those with focal seizures, n = 8). The differentiated coupling of seizure type with seizure onset, in addition to our multivariable regression, may be of particular interest to neurologists and neuro-oncologists responsible for long-term monitoring of the studied population. 
Conclusion
Clinical data linking intracranial brain tumors with the onset of postoperative seizures in children is limited. [37] [38] [39] [40] This study aimed to identify the demographic, pathological, and surgical risk factors for postoperative seizure development in pediatric patients undergoing resection of supratentorial tumors, a subpopulation not previously studied.
Risk factors-tested for robustness with multivariable regression and listed in order of decreasing strength of effect-included: temporal lobe location, age less than 2 years, preoperative hydrocephalus, preoperative seizure, and parietal lobe location. While these results were not surprising with respect to tumor location, seizure status, and age, the identification of hydrocephalus as a risk factor for seizure onset is a novel finding. Altogether these comprise a concise and intelligible array of factors-easily ascertained from clinical presentation and initial MRI-that empowers the patient's team of neurosurgeons, neurologists, and neuro-oncologists to help in adjustment of treatment strategies pre-and-post-resection as well as during clinical follow-up. Institutions that promote the prophylactic prescription of AEDs to pediatric patients recovering from resection of intracranial tumor should evaluate the necessity of this practice with respect to the risk factors identified herein. Further prospective institutional studies capable of a robust analysis of the demographic, surgical, and pathological risk factors for seizures in this setting are warranted.
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